No headlines found.
No press releases found.
No news found.
cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD and hempMD. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD bath bombs, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.
Cbdmd trades on the AMEX stock market under the symbol YCBD.
As of March 28, 2024, YCBD stock price declined to $0.99 with 19,150 million shares trading.
YCBD has a beta of 1.23, meaning it tends to be more sensitive to market movements. YCBD has a correlation of 0.02 to the broad based SPY ETF.
YCBD has a market cap of $3.01 million. This is considered a Sub-Micro Cap stock.
Last quarter Cbdmd reported $5 million in Revenue and -$.67 earnings per share. This fell short of revenue expectation by $-425,000 and exceeded earnings estimates by $.07.
In the last 3 years, YCBD stock traded as high as $189.90 and as low as $.56.
The top ETF exchange traded funds that YCBD belongs to (by Net Assets): VXF.
YCBD stock has underperformed the market in the last year with a return of -88.7%, while SPY returned +33.6%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in YCBD shares. However, YCBD has outperformed the market in the last 3 month and 2 week periods, returning +39.4% and +41.4%, while SPY returned +10.1% and +1.7%, respectively. This indicates YCBD has been having a stronger performance recently.
YCBD support price is $.92 and resistance is $1.10 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that YCBD stock will trade within this expected range on the day.